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Explaining the concept of randomisation in simple terms to patients during the discussion of randomised clinical trials can be a
difﬁcult task for many health care professionals. We report the results of a questionnaire-based survey, using seven
descriptions of randomisation taken from Corbett’s study. We examined the preferences of the general public and patients
towards the descriptions and compared the results with the clinicians’ choice. Participants in the survey were 341 lay people
without cancer, 200 patients with cancer and 200 oncologists from cancer centres throughout the UK. It was difﬁcult to
identify ‘the best’ way to describe the process of randomisation. The two most favoured statements for patients and members
of the public included a very explicit statement that mentioned ‘a computer’, ‘chance’ and ‘not the doctor’s or patient’s
decision’ and a succinct statement that played down the role of ‘chance’. Clinicians chose neither of these statements as
closely resembling their own practice. Patients and members of the public most disliked the statement ‘a computer will
perform the equivalent of tossing a coin to allocate you to one of two methods of treatment’. This analogy used by 26% of
oncologists, was viewed as trivialising and upsetting in the context of determining treatment for life threatening disease.
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There is a large pool of patients eligible to participate in rando-
mised controlled trials (RCT) for new cancer therapies; however,
accrual rates are very low (Ward et al, 1992). With the recent
publication of the House of Commons Report and Proceedings
of the Science and Technology Committee entitled ‘Cancer
Research – A Fresh Look’ (July 2000), there is increasing pressure
to recruit patients into trials. The Committee recommends that:
‘Increasing the number of adult cancer patients entering clinical
trials must become a high priority. We recommend that the
Government sets challenging and speciﬁc targets for the proportion
of eligible adult cancer patients entering clinical trials for all the
most common cancers’. (Department of Health, 2000)
The Government acknowledges the Committees’ recommenda-
tion and aims for the newly formed NHS Cancer Research
Network to double the number of patients entering trials within
3 years (ibid). It is essential then, to consider and address some
of the possible causes for the poor accrual rates. Randomised clin-
ical trials pose particular problems, and the concept of
randomisation raises many issues for both health care professionals
and patients alike.
For clinicians, the business of discussing randomisation with
their patients can be fraught with many difﬁculties, raising both
professional dilemmas and personal conﬂicts. These include: the
pressures created by the changes in the delivery of cancer services
(Smyth et al, 1994), concern about ethical and medico-legal issues
(Shelton, 2001), and the attitudes of both patients (Llewellyn-
Thomas et al, 1991; Wingerson et al, 1993; Fallowﬁeld et al,
1998) and doctors (Fallowﬁeld et al, 1997; Taylor et al, 1984).
Some oncologists have highlighted that the actual task of explain-
ing randomisation and obtaining informed consent can be
particularly complex in the context of cancer (Fallowﬁeld et al,
1998; Jenkins et al, 1999).
It is clear that for some patients, understanding the concept of
randomisation and its implications is difﬁcult to grasp, leading to
confusion and perhaps, reluctance to enter a particular trial
(Cook-Gotay, 1991). In a previous study (Corbett et al, 1996) favour
was found for the less explicit explanations of randomisation, the
ones that played down the role of chance. However, these opinions
came from a small non-representative group of people and as the
authors point out, opinions may differ in patients with a life threa-
tening disease. Doctors acknowledge that they have difﬁculty in
explaining the principles of RCTs to anxious patients seeking reas-
surance and certainty about optimal treatments. The Science and
Technology Committee (Department of Health, 2000) recommends
that stronger safeguards are put in place to ensure that informed
consent is obtained from all patients before enrolment into a clinical
trial. Many have focused on the importance of document readability
for patients considering entry to trials (e.g., Hochhauser, 1999;
Bjorn et al, 1999), while others report that few patients actually read
the information sheets (Corbett et al, 1996) and that the usefulness
of written information correlates highly with the educational level of
the patient (Hietanen et al, 2000). Previous work by the authors
showed that one of the top reasons for patients’ accepting trial entry
is ‘trust in the doctor’ (Jenkins and Fallowﬁeld, 2000) – implying
that the act of communication has a greater inﬂuence on the
patient’s decision than the written word. Therefore, it is vital to
try to establish some clear language guidelines to explain randomi-
sation so that a patient can make an educated decision about
whether or not to participate in a clinical trial.
This study aims to examine whether there is a preferred way to
describe the randomisation process that may facilitate discussions
about clinical trials of cancer therapy.
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Questionnaire (adapted)
The introduction to each questionnaire began with a short
scenario. Members of the public without cancer were asked to:
‘Imagine that you have recently been diagnosed with cancer and
have an appointment with a specialist to talk about how to treat
your condition. The specialist tells you that there is a research trial
going on in the hospital comparing two treatments, both of which
are suitable for your illness. However, the only scientiﬁc way to
compare one treatment with another is for the choice between
the two treatments to be made randomly.’ And patients with
cancer were asked to: ‘Imagine that you have an appointment with
a specialist to talk about how to treat your condition. The specialist
tells you there is a research trial going on in the hospital compar-
ing two treatments both of which are suitable for your illness.
However, the only scientiﬁc way to compare one treatment with
another is for the choice between the two treatments to be made
randomly.’
Both groups were then presented with seven statements (in a
balanced order) explaining randomisation (see Table 1) and were
asked to rate the clarity of each statement on a scale of 0–10 (0
being ‘not at all clear’ and 10 being ‘very clear’). Participants were
also asked to select their most and least preferred description and
give a reason for their choice. Clinicians were sent only the seven
statements and asked to select which description best reﬂected the
one they used when discussing trials with patients. A comments
box was also provided, allowing the doctors to add their own
variations or elaborate on the reasons for their choice, (Corbett
et al, 1996).
SAMPLE
Members of the public
A convenience sample of 341 members of the general public parti-
cipated in the survey. They were approached by a member of the
research team in a variety of public and work places throughout
the South East of England, e.g. railway stations, shopping centres
etc. Approximately one in three people approached declined to
complete the questionnaire.
Patients
A convenience sample of patients in the local oncology out patient
department waiting area was invited to join the study. Two
hundred patients participated and 19 patients declined to take part;
the reasons for refusal were: ‘no reading glasses with them’ (n=6),
‘felt too tired/unwell’ (n=7), ‘anxious about their appointment’
(n=3) and ‘found the questionnaire confusing’ (n=3 older
patients). The majority of patients were women with breast cancer
(23.5%), men with prostate cancer (17.5%) and patients with
colorectal cancer (14.5%). The demographic characteristics of both
patients and members of the public are shown in Table 2.
Clinicians
Two hundred and sixty-seven clinicians working in UK cancer
centres were sent the questionnaire listing the seven statements,
and 200 (75%) returned the questionnaire. Table 3 shows the
distribution of the group by sex and specialty. The number of trials
that clinicians said they were engaged with varied from 0 to 30
(mean ﬁve, mode three).
RESULTS
Clarity of statements
All participants recorded the clarity for each statement on a scale of
0 to 10. The mean, median, modes are shown in Table 4.
Members of the public
Unlike Corbett’s study (Corbett et al, 1996) where a signiﬁcant
advantage was found for Statement ‘F’, members of the public
rated all the statements as fairly clear. We examined differences
in rating of clarity for each statement by sex and age groups.
There were no signiﬁcant differences in ratings between the
men and the women when multiple comparisons were taken into
account.
Patients
Again the data are positively skewed, showing that all the state-
ments appeared clear, but unlike the general public, the patients
rated the statements all slightly higher. There were no signiﬁcant
differences between the sexes in the rating of clarity for each state-
ment or differences between age groups.
Preferred choice of statement
Figure 1 illustrates the similarities and differences between the
choice of statements used by the clinicians and the statements most
preferred by the patients and members of the public. Chi square
and Student’s t-tests were applied to the data where appropriate.
Members of the public
Three hundred and twenty-two members of the public had one
preferred statement, nine did not make a choice, six liked them
all and four people did not like any of the statements. Of those
who did make a choice, 28% (91 out of 322) preferred Statement
‘A’ ‘Once you have agreed to enter the trial, a computer will
randomly allocate you to one of two possible methods of treat-
ment.’ This is the most succinct statement with the fewest words.
It is the least descriptive as it does not mention ‘chance’, that
neither the doctor not the patient will choose the treatment arm,
or include an analogy. However, second favourite, chosen by
20% (64 out of 322) of the sample, contained all of these phrases
(Statements ‘E’). We examined whether there was a preference for
statements according to sex or age group (under or over 60 years).
In both age groups Statement ‘A’ was the favourite choice (29%
(60 out of 204) and 26% (31 out of 118) respectively) and
remained so for both the men (31% (41 out of 132)) and women
(26% (50 out of 190)).
The statements least preferred by members of the public were
Statement ‘F’ (21% (67 out of 315)) ‘Once you have agreed to
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Table 1 The seven descriptions of the randomisation process
A A computer will randomly allocate you to one of two possible methods of
treatment
B A computer will perform the equivalent of tossing a coin
C You will be randomly allocated to one of two possible methods of treatment
by chance alone, independent of who you are and who your doctor is
D A computer will perform the equivalent of drawing names out of a hat
E A computer not a doctor will decide which of the two treatments to give you,
decision will be random and due to chance alone, and not based on the
patient’s or doctor’s decision
F You will be allocated to one of two treatments with equal chances of each
treatment being the one you will receive
G One of two methods of treatment will be chosen by chance, and not by a
decision made by the patient or the doctor
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equal chances of each treatment being the one you will receive’ and
Statement ‘B’, ‘Once you have agreed to enter the trial, a computer
will perform the equivalent of tossing a coin to allocate you to one
of two methods of treatment’ (21% (66 out of 315)). Again we
looked at the effect age and sex had on these choices. The younger
group (under 60 years) disliked Statement ‘F’ the most (23% (48
out of 204)) but the older age group disliked Statement ‘B’ (24%
(27 out of 111)). Women disliked the term ‘tossing a coin’ (22%
(40 out of 184)) while the men disliked ‘equal chances’ (23%
(30 out of 131)).
Patients
One hundred and sixty patients chose one statement that they
preferred, eight did not make a choice, 14 liked them all and
18 did not like any. Of the patients who made a choice, there
were three favourites ‘A’ (24% (38 out of 160)), ‘E’ (24% (39
out of 160)) and ‘F’ (23% (37 out of 160)), similar to the choice
of general public. The younger age group had a clear preference
for Statement ‘A’ (27% (25 out of 91)) and the older group
preferred Statement ‘F’ (29% (20 out of 69)). In addition, men
had a preference for Statement ‘A’ (26% (21 out of 82)) and
the women preferred Statements ‘E’ (29% (23 out of 78)) and
‘F’ (28% (22 out of 78)). When we looked at sex by age group
in a little more detail we noted a difference between the sexes.
The younger men nominated Statement ‘A’ as ﬁrst choice (30%
(11 out of 36)) and the younger women chose ‘E’ (31% (17
out of 55)). Similarly there were different preferences in the older
age group between the men and women, with men choosing ‘E’
(24% (11 out of 46)) and women overwhelmingly choosing ‘F’
(48% (11 out of 23)).
The patients’ least favourite statement was ‘B’ (31% (50 out of
160)), similar to the general public. When we looked at the affect
age had on patients’ choice of statement we found that both age
groups disliked Statement ‘B’ (tossing a coin) (31% (27 out of
88), 32% (23 out of 72)). This statement was equally unpopular
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Table 2 Members of the public and patients’ characteristics
Public
(n=341) (%)
Patients
(n=200) (%)
Sex
Male 143 (42) 104 (52)
Female 198 (58) 96 (48)
Previous Trial Experience 9 (3) 15 (7.5)
Age
Under 60 years 212 (62) 103 (51.5)
Over 60 years 129 (38) 97 (48.5)
Education
University 102 (29.9) 39 (19.5)
Professional qualiﬁcation 96 (28.2) 44 (22)
A levels 26 (7.6) 16 (8)
O levels 61 (17.9) 33 (16.5)
Other exams 13 (3.8) 11 (5.5)
Nil 42 (12.3) 57 (28.5)
Missing 1 (0.3) –
Social Class
1/1.2 Professional 61 (17.8) 33 (16.5)
2 Managerial 73 (21.4) 49 (24.5)
3 Skilled manual 81 (23.8) 54 (27)
4 Partly skilled 10 (2.9) 9 (4.5)
5 Unskilled 22 (6.5) 16 (8)
6 Armed forces 30 (8.8) 18 (9)
7 Unemployed 18 (5.3) 7 (3.5)
Housewife/student 33 (9.7) 12 (6)
Missing 13 (3.8) 2 (1)
Table 3 Clinicians’ characteristics (n=199; 1 missing)
Medical
oncologist
Clinical
oncologist Surgeon Other Total
Male 55 47 53 8 163
Female 18 14 2 2 36
Total 73 61 55 10 199
Clinicians n=174 Public n=322 Patients n=160
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Figure 1 Shows the preferred choice of statements by the clinicians,
public and patients.
Table 4 Members of the public and patients’ clarity ratings for the seven statements
Public n=341 Patients n=200
Statement Mean Median Mode Min Max Mean Median Mode Min Max
A 6.76 9 10 0 10 7.8 9 10 0 10
B 6.86 8 10 0 10 7.54 8.5 10 0 10
C 7.01 8 10 0 10 7.55 8 10 0 10
D 7.06 8 10 0 10 7.86 9 10 0 10
E 7.14 8 10 0 10 7.61 8 10 0 10
F 6.84 7 10 0 10 7.73 9 10 0 10
G 7.08 8 10 0 10 7.69 8 10 0 10
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(27 out of 76)).
Both the public and patients gave reasons for their choice of
statement describing the process of randomisation. The main
reason people chose Statement ‘A’ appeared to be because of its
brevity and ‘straightforward approach’. Comments included: ‘To
the point’, ‘very clear and concise’, ‘short–easy to understand’
and ‘very clear and not patronising’. Whereas those who chose
Statement ‘E’ appeared to want more detail, for example ‘it
includes all relevant factors – computer, doctor, random, by
chance’, ‘it gives more information to me’, ‘it is clear but gives
more information as to how the decision is made’, ‘It’s slightly
longer explanation gives more opportunity for the information to
be assimilated’.
When we look at reasons why Statement ‘B’ was overwhelmingly
disliked we found that both patients and the public had similar
attitudes. One member of the public wrote, ‘If I had cancer I
would not like to think of my fate resting on the toss of a coin’,
others that it was ‘frightening’, ‘although clear this is trivialising
and could be extremely upsetting’. Patients had similar views,
‘too much like a prize draw’, ‘tossing a coin makes it seem like
a lottery-which of course it is’. A more suspicious patient wrote,
‘They might use a two headed coin’.
Clinicians
Two hundred and seventy clinicians were invited to participate in
the survey, 200 (74%) responded, (164 men, 36 women). Of these
clinicians 129 (64.5%) chose one statement that closely resembled
their own practice, 45 chose a combination of statements and 26
provided the phrase they actually used to describe randomisation
to patients. Of the 71 clinicians who chose more than one state-
ment or provided their own version, 43 (60%) provided an
explanation for their choice. Several stated that they used different
phrases according to the patient’s (perceived) educational level;
others used the term ‘50:50 chance’, and some favoured a combi-
nation of phrases.
The most frequently chosen description (among the group of 174
clinicians) was Statement ‘F’ ‘Once you have agreed to enter the trial,
you will be allocated to one of two treatments with equal chances of
each treatment being the one you will receive’. This was chosen by
32% (56 out of 174) of the respondents, closely followed by State-
ment ‘B’ (26% (45 out of 174)) ‘Once you have agreed to enter
the trial, a computer will perform the equivalent of tossing a coin
to allocate you to one of two methods of treatment’. When we exam-
ined the data by sex and specialty (medical oncologist, clinical
oncologist, surgeon and physician) we noted some interesting differ-
ences. The most popular choices for women were Statements ‘E’ and
‘F’ (34% (11 out of 32) in each case); whereas men nominated State-
ments ‘F’ and ‘B’ (32% (45 out of 142) and 28% (40 out of 142)
respectively). There were differences in choice between specialties
too, with medical oncologists most frequently nominating Statement
‘B’ (27% (18 out of 66)), clinical oncologists nominating Statements
‘F’ and ‘G’ (33% (17 out of 51) in each case) and the surgeons choos-
ing Statement ‘F’ (40% (19 out of 48)). The nominations of the
‘other’ specialty of eight clinicians (chest physicians and palliative
care consultants) were more diverse.
Comparison of the clinicians’ main choice of statement with
that of the public and the patients revealed that Statement ‘F’
was supported by 23% (37 out of 160) of patients and by 19%
(60 out of 322) of the public. However, a similar number both
of the patients and the public disliked Statement ‘F’ (18% (29
out of 160) and 21% (67 out of 315) respectively), suggesting a
polarisation of views. In contrast, clinicians second choice, State-
ment ‘B’ was nominated as the least favourite description by the
majority of patients (31% (50 out of 160) and 21% (66 out of
315)) of the public.
The statement that clinicians voted as the one they most
frequently used (F) was voted as unpopular by as many patients
and members of the public as those who liked it. The reasons given
for its popularity are that ‘no mention of chance or coins – more
professional and reassuring – implies equal treatments’, ‘no
mention of a computer or randomisation’ and ‘because I feel it will
not be a chance decision’. The members of the public who disliked
it stated ‘difﬁcult to understand – may confuse a patient’, ‘verbally
confusing’, and ‘it does not explain the allocation process and it
adds doubt to confusion’. Patients who did not like this explana-
tion, amongst them a journalist and an accountant, said it was
‘gobbledegook’ and ‘wafﬂe’.
DISCUSSION
Previous research in the area of informed consent has highlighted
that the emphasis given to chance in the explanation of the
concept of randomisation causes considerable unease amongst
patients and the general public (Featherstone and Donovan,
1998; Corbett et al, 1996; Fallowﬁeld et al, 1998; Jenkins and
Fallowﬁeld, 2000). The results from our survey provide clear
information on how not to describe the process to patients and
potential patients. Speciﬁcally, women and older members of
the public disliked the common analogy – ‘toss of a coin’,
though this was the second most frequently stated phrase amongst
our clinicians. Everyone who chose this as their most disliked
statement also gave a reason for their choice, which stresses the
emotive nature of this phrase. Although using analogies such as
ﬂipping coins are expressive and animated, they appear to trivia-
lise the larger issues implicit for patients contemplating cancer
trials. Many patients would not anticipate a consultation in which
uncertainty and randomisation are discussed, especially at a time
when life itself seems so uncertain. Therefore to trivialise the
matter, albeit unintentionally, may inadvertently harm the
doctor–patient relationship.
In contrast, it was far more difﬁcult to identify ‘the best’ way to
describe the process of randomisation. We thought that older
people would not like the idea of a ‘computer choosing their treat-
ment’ because as a generation they may be more suspicious of
technology. This suggestion was not found to be statistically signif-
icant although older patients did favour statements that did not
mention a computer more than the younger age group. In addi-
tion, there was a polarisation of views for Statement ‘F’ – which
clinicians chose as the closest reﬂection of their own practise. Older
patients and women patients preferred it but younger members of
the public disliked it.
In contrast to Corbett’s study (Corbett et al, 1996) there were
no signiﬁcant differences in the ratings of clarity between the state-
ments, suggesting that the wording was simple to read but we did
not explicitly check the patients’ and public’s understanding of the
different statements. Also we are aware that participants’ read the
statements yet during a consultation they would hear them – a
very different mode of communication and one that may be more
prone to interference. Complementing Corbett’s results the state-
ment ‘tossing a coin’ was strongly disliked by both groups of
participants. Unfortunately, this term is used very often in hospital
patient information sheets to describe the process of randomisa-
tion – perhaps it is time to change.
Clinicians and other health professionals are under considerable
pressure to provide clear information about clinical trials in an
understandable way to patients. This pressure comes not only
from Government but also from patient lobby groups. In the Fifth
Revision of the Declaration of Helsinki (WMA, 2000) there were
many gains for the rights of consumers. The ‘obligation to ensure
people have understood the information provided to them before
entering a study’ is one highlighted in an article in the BMJ (Toll-
man et al, 2001). Yet despite all the arguments surrounding trials,
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discuss trials with patients. One group have produced a compre-
hensive DIY guide on ‘how to do it’ but concluded that the
process is not easy and that doctors need to develop good
communication skills to enable patients to make a properly
informed decision on whether or not to participate in clinical
trials (Wager et al, 1995).
Unfortunately, a fundamental factor in poor trial recruitment,
and the unacceptably low understanding exhibited by patients
about the trials they join, is the inadequate communication skills
of doctors (Fallowﬁeld and Jenkins, 2001) Discussing trials is extre-
mely difﬁcult and doctors need more education and understanding
about patient attitudes as well as training in effective communica-
tion skills if the situation is to improve. Flexibility of approach and
a better grasp of what members of the public comprehend by
words and phrases commonly used by doctors are just one part
of the process.
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